CartiMax®

Viable Cartilage Allograft

CartiMax® Instruments Product Overview

CartiMax® is viable, cartilage fibers combined with cartilage allograft matrix to make a biologically-active scaffold with putty-like handling characteristics used to treat focal cartilage defects.  This product offers the potential to facilitate cartilage healing and regeneration along with ease of use.

Viable Chondrocytes
Characterization testing of CartiMax verifies the presence of functioning viable chondrocytes & chondrogenic growth factors.1 Multiple studies have demonstrated that chondrocytes migrate and proliferate from the cartilage fibers and secrete components found in hyaline cartilage.2,3,4

Optimal Handling Properties
Unlike other solutions that may require templates, trimming, gluing, suturing or other fixation methods, CartiMax has putty-like handling properties and easily conforms to defects of different shapes and sizes.

12 Month Shelf-Life
A ready-to-go, off-the-shelf solution that demonstrates stable viability up to twelve months post-cryopreservation.1

High Volume of Material
While you may need multiple packages of another scaffold to fill a 2.5cm2 lesion, one package of CartiMax contains enough cartilage matrix to fill up to a 5cm2 lesion. Other products may require multiple packages to fill the same volume.

Reference:
1Data on File, MTF Biologics.

2Albrecht F, Roessner A, Zimmermann E. Closure of osteochondral lesions using chondral fragments and brin adhesive. Archives of orthopaedic and traumatic surgery Archiv fur orthopadische und Unfall-Chirurgie. 1983;101:213–7. [PubMed].

3Lu Y, Dhanaraj S, Wang Z, et al. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2006;24:1261–70. [PubMed].

4Frisbie DD, Lu Y, Kawcak CE, DiCarlo EF, Binette F, McIlwraith CW. In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. The American journal of sports medicine. 2009;37(Suppl 1):71S–80S.

 

  1. Videos & Documents


    LITERATURE

    CartiMax Sell Sheet
    CartiMax Cell Markers – Whitepaper
    CartiMax Retention Study – Whitepaper
    CartiMax Viability – Whitepaper

  2. Specifications and Ordering Information
    CartiMax™ Viable Cartilage Allograft
    CAT # 401205
  3. Customer Service

    POOYA TEB BARABARAN is Exclusive representation of ConMed corporation in IRAN.

    We are committed to providing our customers with best-in-class customer service.

     For more tips on this product click the link Contact us and get in touch with us.


This content has been copied from This link of Conmed's official website.
Pooya Teb Barabaran is an Exclusive Representative of ConMed Corporation in IRAN.